Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women

(2012) Angela Watt et al.   Infectious Agents and Cancer

Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes

(2010) Johanna Palmroth et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women

(2009) Marjo Kaasila et al.   INTERNATIONAL JOURNAL OF CANCER

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children

(2009) S. S. Huang et al.   PEDIATRICS

Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda

(2008) Cecily Banura et al.   INTERNATIONAL JOURNAL OF CANCER